Actuate Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Actuate Therapeutics Inc 's ROA in the second quarter of 2026?
Actuate Therapeutics Inc recorded a cumulative net loss of $-20 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -178.4%.

However, within the Healthcare sector 836 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4460, from total ROA ranking in the first quarter of 2026 at 5193.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-25.39 %	98.78 %	50.63 %	24.2 %	302.63 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-20	-22	-22	-24	-25
Return On Assets (TTM)	-178.4 %	-180.87 %	-205.81 %	-250.7 %	-281.83 %
ACTU's Total Ranking	# 4460	# 5193	# 4655	# 4739	# 4844
Total Assets (TTM) in million	5	9	14	18	7
Seq. Total Assets Change	-41.65 %	-36.51 %	-20.76 %	154.19 %	55.45 %
Seq. Net Income Change	-	-	-	-	-

ACTU's 5 Years Annual ROA >> Back to ACTU Management Effectiveness >> Compare ACTU ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 398
Sector	# 837
Overall	# 4408

Return On Assets Statistics
High	Average	Low
-178.4 %	-260.41 %	-385.55 %
(Jun 30 2026)		(Dec 31 2024)

Financial Statements
Actuate Therapeutics Inc 's Assets	$ 5 million	ACTU's Balance sheet
Actuate Therapeutics Inc 's Income	$ -5 million	Quarterly ACTU's Income Statement
ACTU's Income by Division		See ACTU's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	50.63 %	-	-	-	-
Total Assets in million	14	9	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-22	-27	0	0	0
Annual Return On Assets	-158.36 %	-292.81 %	-	-	-

ACTU's 5 Years Annual ROA >> Back to ACTU Management Effectiveness >> Compare ACTU ROA to its Competitors

More Return On Assets Ratios
ACTU's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ACTU's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ACTU's Competitors
Subscribers only: Roa for Actuate Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for ACTU's Customers

You may also want to know
ACTU's Roi	ACTU's Inventory Turnover Ratio	ACTU's Growth Rates	ACTU's Dividend Comparisons
	ACTU's Profitability Ratios	ACTU's Asset Turnover Ratio	ACTU's Dividend Growth
ACTU's Roe	ACTU's Valuation Ratios	ACTU's Financial Strength Ratios	ACTU's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-15T03:14:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.